199 related articles for article (PubMed ID: 32764422)
1. Incidence of Tuberculosis in Inflammatory Rheumatic Diseases: Results from a Lithuanian Retrospective Cohort Study.
Miltinienė D; Deresevičienė G; Nakčerienė B; Davidavičienė VE; Danila E; Butrimienė I; Dadonienė J
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32764422
[No Abstract] [Full Text] [Related]
2. Risk of tuberculosis, serious infection and lymphoma with disease-modifying biologic drugs in rheumatoid arthritis patients in Taiwan.
Chiu YM; Lang HC; Lin HY; Yang MT; Fang CH; Yang YW; Schabert VF; Tang B
Int J Rheum Dis; 2014 Dec; 17 Suppl 3():9-19. PubMed ID: 25496045
[TBL] [Abstract][Full Text] [Related]
3. Mortality in Inflammatory Rheumatic Diseases: Lithuanian National Registry Data and Systematic Review.
Dadonienė J; Charukevič G; Jasionytė G; Staškuvienė K; Miltinienė D
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886062
[TBL] [Abstract][Full Text] [Related]
4. How Did the Two Years of the COVID-19 Pandemic Affect the Outcomes of the Patients with Inflammatory Rheumatic Diseases in Lithuania?
Dadonienė J; Jasionytė G; Mironova J; Staškuvienė K; Miltinienė D
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837512
[No Abstract] [Full Text] [Related]
5. [Biologics and mycobacterial diseases].
Tsuyuguchi K; Matsumoto T
Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
[TBL] [Abstract][Full Text] [Related]
6. One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
Lim CH; Lin CH; Chen DY; Chen YM; Chao WC; Liao TL; Chen HH
PLoS One; 2016; 11(11):e0166339. PubMed ID: 27832150
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis in people with rheumatic disease in Finland 1995-2007: a nationwide retrospective register study.
Vuorela M; Mars NJ; Salonen J; Kauppi MJ
Rheumatol Adv Pract; 2019; 3(2):rkz020. PubMed ID: 31528842
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
9. Cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
Drevinskaite M; Kaceniene A; Patasius A; Stukas R; Germanavicius A; Miseikyte E; Urbonas V; Smailyte G
Acta Psychiatr Scand; 2024 Mar; 149(3):234-243. PubMed ID: 38173088
[TBL] [Abstract][Full Text] [Related]
10. Variation in incidences of tuberculosis in subgroups of South African gold miners.
Kleinschmidt I; Churchyard G
Occup Environ Med; 1997 Sep; 54(9):636-41. PubMed ID: 9423575
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis in Poland in 2014.
Korzeniewska-Koseła M
Przegl Epidemiol; 2016; 70(2):261-272. PubMed ID: 27824436
[TBL] [Abstract][Full Text] [Related]
12. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis in Poland in 2017.
Korzeniewska- Koseła M
Przegl Epidemiol; 2019; 73(2):211-226. PubMed ID: 31385679
[TBL] [Abstract][Full Text] [Related]
14. Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study.
Aydin V; Akici A; Isli F; Aksoy M; Aydin M; Gursoz H
J Clin Pharm Ther; 2019 Aug; 44(4):553-560. PubMed ID: 30763469
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment.
Sartori NS; Picon P; Papke A; Neyeloff JL; da Silva Chakr RM
PLoS One; 2019; 14(12):e0224963. PubMed ID: 31790428
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada.
Brassard P; Lowe AM; Bernatsky S; Kezouh A; Suissa S
Arthritis Rheum; 2009 Mar; 61(3):300-4. PubMed ID: 19248128
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis in Poland in 2016.
Korzeniewska-Koseła M
Przegl Epidemiol; 2018; 72(2):189-205. PubMed ID: 30111079
[TBL] [Abstract][Full Text] [Related]
18. The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.
Cho SK; Lee J; Han M; Bae SC; Sung YK
Arthritis Res Ther; 2017 Dec; 19(1):277. PubMed ID: 29246243
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis in Poland in 2013.
Korzeniewska-Koseła M
Przegl Epidemiol; 2015; 69(2):277-82, 389-93. PubMed ID: 26233087
[TBL] [Abstract][Full Text] [Related]
20. Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.
Wadström H; Frisell T; Askling J;
JAMA Intern Med; 2017 Nov; 177(11):1605-1612. PubMed ID: 28975211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
